TRM Labs says the $17.9 billion figure reflects gross onchain volume, including internal transfers, not confirmed illicit proceeds.
You might also be interested in reading Johnson & Johnson Q2 Preview: Focus on tariff threat, MedTech softness.
CoinTelegraph